The Future of Cancer Treatment: OX40 Ligand Inhibitors on the Rise
the pharmaceutical landscape is witnessing a paradigm shift in immunotherapy approaches, with OX40 ligand inhibitors emerging as a promising therapeutic strategy for treating various inflammatory and autoimmune conditions
